| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4007519 | Archivos de la Sociedad Española de Oftalmología | 2011 | 5 Pages |
Abstract
Patients treated for 3 months with Combigan® showed a significant decrease of CRA resistive index that could be explained by the decrease in IOP.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
B. Puerto-Hernández, G. Rebolleda, J.L. GarcÃa-Pérez, F.J. Muñoz-Negrete, C. González-Gordaliza,